fibrosis: affect growth

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents complication
Weight: 0.54
, problem
Weight: 0.53
, condition
Weight: 0.49
, disease
Weight: 0.48
, feature
Weight: 0.48
Siblings cystic fibrosis
Weight: 0.36
, pulmonary edema
Weight: 0.35
, myocardial infarction
Weight: 0.35
, pelvic inflammatory disease
Weight: 0.35
, atherosclerosis
Weight: 0.34

Related properties

Property Similarity
affect growth 1.00
affect development 0.82

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.09
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth) ⋁
Evidence: 0.68
¬ Remarkable(cystic fibrosis, affect growth)
0.06
Rule weight: 0.13
Evidence weight: 0.56
Similarity weight: 0.82
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth) ⋁
Evidence: 0.88
¬ Remarkable(cystic fibrosis, affect development)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.55
Plausible(fibrosis, affect growth) ⋁
Evidence: 0.68
Remarkable(cystic fibrosis, affect growth) ⋁
Evidence: 0.63
¬ Plausible(cystic fibrosis, affect growth)
0.48
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.82
Evidence: 0.55
Plausible(fibrosis, affect growth) ⋁
Evidence: 0.88
Remarkable(cystic fibrosis, affect development) ⋁
Evidence: 0.61
¬ Plausible(cystic fibrosis, affect development)

Salient implies Plausible

0.21
Rule weight: 0.28
Evidence weight: 0.75
Similarity weight: 1.00
Evidence: 0.55
Plausible(fibrosis, affect growth) ⋁
Evidence: 0.56
¬ Salient(fibrosis, affect growth)

Similarity expansion

0.51
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.63
Typical(fibrosis, affect growth) ⋁
Evidence: 0.73
¬ Typical(fibrosis, affect development)
0.47
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.82
Evidence: 0.55
Plausible(fibrosis, affect growth) ⋁
Evidence: 0.74
¬ Plausible(fibrosis, affect development)
0.44
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.56
Salient(fibrosis, affect growth) ⋁
Evidence: 0.86
¬ Salient(fibrosis, affect development)
0.43
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.82
Evidence: 0.49
Remarkable(fibrosis, affect growth) ⋁
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.56
Salient(fibrosis, affect growth) ⋁
Evidence: 0.63
¬ Typical(fibrosis, affect growth) ⋁
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth)

Typical implies Plausible

0.34
Rule weight: 0.48
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.55
Plausible(fibrosis, affect growth) ⋁
Evidence: 0.63
¬ Typical(fibrosis, affect growth)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.68
Similarity weight: 1.00
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth) ⋁
Evidence: 0.64
¬ Typical(cystic fibrosis, affect growth)
0.08
Rule weight: 0.14
Evidence weight: 0.76
Similarity weight: 0.82
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth) ⋁
Evidence: 0.49
¬ Typical(cystic fibrosis, affect development)